Trade Mark Journal No.2025/040 3 October 2025

UK00004268021 23 September 2025 (5)

REVYVE

Class 5: Antimicrobial wound gels; topical antimicrobial preparations for inhibiting bacteria in wounds; antimicrobials for dermatologic use; topical preparations for treating diabetic foot ulcers, leg ulcers, pressure ulcers, first- and second-degree burns, partial- and full-thickness wounds, large surface area wounds, and surgical incisions .

Kane Biotech Inc

Representative: Freeths LLP